We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · September 02, 2020

Integration of Tumor-Infiltrating Lymphocytes, PD-L1, CD8, and FOXP3 in Prognostic Models for Triple-Negative Breast Cancer

European Journal of Cancer


Additional Info

European Journal of Cancer
Integration of Tumour Infiltrating Lymphocytes, Programmed Cell-Death Ligand-1, CD8 and FOXP3 in Prognostic Models for Triple-Negative Breast Cancer: Analysis of 244 Stage I-III Patients Treated With Standard Therapy
Eur. J. Cancer 2020 Sep 01;136(136)7-15, MV Dieci, V Tsvetkova, G Griguolo, F Miglietta, G Tasca, CA Giorgi, E Cumerlato, D Massa, M Lo Mele, E Orvieto, V Guarneri, P Conte

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading